Gantry-Based 5-Fraction Elective Nodal Irradiation in Unfavorable-Risk Prostate Cancer: Outcomes From 2 Prospective Studies Comparing SABR Boost With MR Dose-Painted HDR Brachytherapy Boost
- 9 October 2021
- journal article
- research article
- Published by Elsevier BV in International Journal of Radiation Oncology*Biology*Physics
- Vol. 112 (3), 735-743
- https://doi.org/10.1016/j.ijrobp.2021.10.003
Abstract
No abstract availableFunding Information
- Prostate Cancer Canada
This publication has 32 references indexed in Scilit:
- Prostate-Specific Antigen at 4 to 5 Years After Low-Dose-Rate Prostate Brachytherapy Is a Strong Predictor of Disease-Free SurvivalInternational Journal of Radiation Oncology*Biology*Physics, 2014
- Stereotactic body radiotherapy for localized prostate cancer: Pooled analysis from a multi-institutional consortium of prospective phase II trialsRadiotherapy and Oncology, 2013
- Multiparametric MRI for prostate cancer localization in correlation to whole‐mount histopathologyJournal of Magnetic Resonance Imaging, 2012
- Dose-Fractionation Sensitivity of Prostate Cancer Deduced From Radiotherapy Outcomes of 5,969 Patients in Seven International Institutional Datasets: α/β = 1.4 (0.9–2.2) GyInternational Journal of Radiation Oncology*Biology*Physics, 2012
- Tumor focality in prostate cancer: implications for focal therapyNature Reviews Clinical Oncology, 2010
- Single-Fraction High-Dose-Rate Brachytherapy and Hypofractionated External Beam Radiotherapy for Men With Intermediate-Risk Prostate Cancer: Analysis of Short- and Medium-Term Toxicity and Quality of LifeInternational Journal of Radiation Oncology*Biology*Physics, 2010
- RTOG GU Radiation Oncology Specialists Reach Consensus on Pelvic Lymph Node Volumes for High-Risk Prostate CancerInternational Journal of Radiation Oncology*Biology*Physics, 2009
- Clinically Significant Prostate Cancer Local Recurrence After Radiation Therapy Occurs at the Site of Primary Tumor: Magnetic Resonance Imaging and Step-Section Pathology EvidenceInternational Journal of Radiation Oncology*Biology*Physics, 2007
- Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus ConferenceInternational Journal of Radiation Oncology*Biology*Physics, 2006
- CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatmentSeminars in Radiation Oncology, 2003